Meridian Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$702K Hold
3,498
0.02% 426
2025
Q4
$722K Sell
3,498
-54
-2% -$10.8K 0.03% 412
2025
Q3
$637K Buy
3,552
+54
+2% +$9.2K 0.02% 424
2025
Q2
$564K Hold
3,498
0.02% 417
2025
Q1
$595K Hold
3,498
0.03% 379
2024
Q4
$581K Hold
3,498
0.03% 380
2024
Q3
$601K Buy
+3,498
New +$579K 0.03% 378
2024
Q1
Sell
-3,498
Closed -$553K 300
2023
Q4
$553K Sell
3,498
-552
-14% -$79.3K 0.04% 364
2023
Q3
$593K Hold
4,050
0.04% 330
2023
Q2
$620K Hold
4,050
0.05% 286
2023
Q1
$628K Hold
4,050
0.05% 286
2022
Q4
$624K Hold
4,050
0.06% 267
2022
Q3
$535K Sell
4,050
-282
-7% -$39.6K 0.06% 264
2022
Q2
$587K Hold
4,332
0.05% 321
2022
Q1
$646K Sell
4,332
-200
-4% -$29.6K 0.07% 201
2021
Q4
$734K Hold
4,532
0.08% 196
2021
Q3
$752K Buy
4,532
+138
+3% +$23.6K 0.09% 178
2021
Q2
$758K Buy
4,394
+62
+1% +$10.2K 0.1% 175
2021
Q1
$695K Hold
4,332
0.1% 173
2020
Q4
$727K Buy
+4,332
New +$703K 0.12% 147
2019
Q3
Sell
-260
Closed -$367 281
2019
Q2
$367 Buy
+260
New +$35.9K 0.01% 421

Other funds holding FBT

Meridian Wealth Management's FBT Position: Q1 2026 in Review

Meridian Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 3,498 shares worth $702K. The position accounts for 0.02% of the portfolio, ranked #426.

Meridian Wealth Management first reported a position in FBT in Q2 2019 and has held it in 21 quarters since. The position peaked at $758K in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Meridian Wealth Management held 3,498 shares of First Trust NYSE Arca Biotechnology Index Fund worth $702K as of Q1 2026.
  • Meridian Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #426 holding.
  • Meridian Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and has held it in 21 quarters since.
  • Meridian Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $758K in Q2 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.